JPH1037018A - Antibacterial cellulose regenerated fiber - Google Patents

Antibacterial cellulose regenerated fiber

Info

Publication number
JPH1037018A
JPH1037018A JP20521296A JP20521296A JPH1037018A JP H1037018 A JPH1037018 A JP H1037018A JP 20521296 A JP20521296 A JP 20521296A JP 20521296 A JP20521296 A JP 20521296A JP H1037018 A JPH1037018 A JP H1037018A
Authority
JP
Japan
Prior art keywords
antibacterial
regenerated
chitosan
cellulose
antifungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20521296A
Other languages
Japanese (ja)
Other versions
JP3413631B2 (en
Inventor
Hiroaki Yabe
博昭 谷邊
Yoshio Ito
由雄 伊藤
Fumio Miyazawa
文雄 宮澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Spinning Co Ltd
Original Assignee
Fuji Spinning Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Spinning Co Ltd filed Critical Fuji Spinning Co Ltd
Priority to JP20521296A priority Critical patent/JP3413631B2/en
Publication of JPH1037018A publication Critical patent/JPH1037018A/en
Application granted granted Critical
Publication of JP3413631B2 publication Critical patent/JP3413631B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Artificial Filaments (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an antibacterial cellulose regenerated fiber having excellent humidity retention and combinedly having antibacterial property, antifungal property and acaricidal property without losing water absorbing property and feeling, etc., of the fiber itself. SOLUTION: This fiber is obtained by adding regenerated chitosan fine particles or regenerated acetylated chitosan fine particles having <=10μm particle diameter, and nitryl-based, pyridine-based, haloalkylthio-based, organic iodine- based, thiazole-based and benzimidazole-based antibacterial agents to cellulose viscose, and spinning the viscose.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、セルロース再生繊維が
本来有する吸水性を損なうことなく、優れた保湿性を有
し、抗菌性、抗カビ性、防ダニ性を同時に具備するセル
ロース再生繊維に関し、糸、編織物、不織布、抄紙等の
原料に供され、衣料分野、衛生材料分野、包装資材分
野、産業資材分野、農業分野等に広く利用される繊維を
提供するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a regenerated cellulose fiber having excellent moisture retention, antibacterial property, antifungal property and anti-mite property without impairing the water absorption inherent in the regenerated cellulose fiber. The present invention provides fibers which are used as raw materials for yarns, knitted fabrics, nonwoven fabrics, papermaking and the like, and are widely used in the fields of clothing, sanitary materials, packaging materials, industrial materials, and agriculture.

【0002】[0002]

【従来の技術】繊維に対して抗菌性、抗カビ性、防ダニ
性を付与する方法としては、繊維製造時に原料中に薬剤
を混合し紡糸する方法、あるいは繊維に加工処理する方
法等が提案されている。従来より用いられていた抗菌性
を与える物質としては、例えば、銀、銅、亜鉛等の金属
イオンを有するものや、塩化ベンザルコニウム、有機シ
リコン系第4級アンモニウム塩、ヘキサメチレンビグア
ナイド塩酸塩等があり、また、抗カビ性を与える物質と
しては、有機チアゾリル化合物、ベンズイミダゾリル化
合物等の有機芳香族型化合物等があり、防ダニ性を与え
る物質としては、殺ダニ剤、忌避剤等がある。そして個
々の薬品を繊維に練込んだり、表面の官能基に化学結合
で固定させること等により、抗菌性、抗カビ性、防ダニ
性を付与した繊維を得ていた。
2. Description of the Related Art As a method for imparting antibacterial properties, antifungal properties, and anti-mite properties to fibers, a method of mixing and spinning chemicals in raw materials at the time of fiber production, or a method of processing into fibers is proposed. Have been. Examples of substances conventionally used to impart antibacterial properties include substances having metal ions such as silver, copper, and zinc, benzalkonium chloride, organosilicon-based quaternary ammonium salts, and hexamethylene biguanide hydrochloride. Also, examples of the substance that imparts antifungal properties include organic thiazolyl compounds and organic aromatic compounds such as benzimidazolyl compounds. Examples of the substance that imparts anti-mite properties include acaricides and repellents. . Then, a fiber having antibacterial properties, antifungal properties, and anti-mite properties has been obtained by kneading individual chemicals into the fibers or fixing them to the functional groups on the surface by chemical bonding.

【0003】しかし、抗菌性、抗カビ性、防ダニ性の対
象となる細菌、カビ、ダニは、生物学的に見ても全く異
なるものであり、それらに抵抗性を有する物質は基本的
に違うものである。従って、抗菌性繊維、抗カビ性繊
維、防ダニ性繊維の如く、細菌、カビ、ダニ、それぞれ
に抵抗性を有する繊維は開発されているが、細菌、カ
ビ、ダニに対して同時に抵抗性を有する繊維は開発され
ていない。
[0003] However, bacteria, molds and ticks which are antibacterial, antifungal and anti-mite properties are completely different from the biological point of view, and substances having resistance to them are basically different. It is different. Therefore, bacteria, molds, ticks, and other fibers having resistance to them, such as antibacterial fibers, antifungal fibers, and anti-mite fibers, have been developed. No fibers have been developed.

【0004】本出願人は特開平4−289211号公報
で、セルロース再生繊維中に粒子径10μm以下の再生
キトサン微小粒状体又は再生アセチル化キトサン微小粒
状体をビスコース中に混合紡糸して繊維中に0.5重量
%以上2.0重量%以下含有させることによって、再生
繊維本来の強度を損なうことなく、染色性を向上させる
と共に耐久性に富む抗菌・脱臭性能を具備した再生セル
ロース繊維を、また、特願平6−308109号で、粒
子径10μm以下の第4級アンモニウム塩化キトサン微
小粒状体をビスコース中に混合紡糸し繊維中に0.3〜
1.6重量%含有させることにより、幅広い抗菌スペク
トルを具備する再生セルロース繊維が得られることを開
示した。これらは、キトサン系の微小粒状体のみをビス
コース中に混合し、紡糸した再生セルロース繊維で、抗
菌性を主たる目的としたものであり、抗カビ性、防ダニ
性を目的としたものではなく、また、カニ、エビ、昆虫
類の外骨格から得られるキトサンに抗菌性や抗カビ性が
あることは既に知られているが、セルース分解性を有す
るカビに対する抵抗性は十分とは言えず、防ダニ性は期
待できない。
[0004] The present applicant discloses in Japanese Patent Application Laid-Open No. Hei 4-289221 that a regenerated chitosan microparticle or a regenerated acetylated chitosan microparticle having a particle diameter of 10 µm or less is mixed and spun into viscose in regenerated cellulose fiber. By adding 0.5% by weight or more and 2.0% by weight or less to a regenerated cellulose fiber having antibacterial and deodorizing performance which is improved in dyeability and durable without impairing the original strength of the regenerated fiber, Also, in Japanese Patent Application No. 6-308109, a quaternary ammonium chloride chitosan fine particle having a particle diameter of 10 μm or less is mixed and spun in viscose, and 0.3 to
It has been disclosed that by containing 1.6% by weight, a regenerated cellulose fiber having a broad antibacterial spectrum can be obtained. These are chitosan-based microparticulates only mixed in viscose and spun regenerated cellulose fibers, which are mainly intended for antibacterial properties, not for antifungal properties, but for anti-mite properties. Also, it is already known that chitosan obtained from the exoskeleton of crabs, shrimps and insects has antibacterial and antifungal properties, but it cannot be said that the resistance to fungi having cellulolytic properties is sufficient. Mite control cannot be expected.

【0005】抗カビ性に関しては、有機チアゾリル化合
物、ベンズイミダゾリル化合物等の有機芳香族系化合物
等の抗カビ性能を有する薬剤を繊維原料中に混合し紡糸
したものはなかった。また,これらの抗カビ剤を繊維上
に固着させることにより該性能を発現させることはでき
るが、繊維上に固着させる方法では繊維本来の吸水性、
保湿性、風合いを損なう結果となり、実用的に欠点があ
る。
[0005] Regarding the antifungal property, there has been no fiber obtained by mixing an agent having an antifungal property such as an organic aromatic compound such as an organic thiazolyl compound or a benzimidazolyl compound into a fiber raw material and spinning. The performance can be exhibited by fixing these antifungal agents on the fibers, but the method of fixing them on the fibers makes it possible to obtain the inherent water absorption of the fibers,
The result is impaired moisture retention and texture, and there is a practical disadvantage.

【0006】また、防ダニ性に関しては、殺ダニ剤、忌
避剤を繊維に固着加工することが行われているが、効果
の耐久性、人体に対する安全性の面が指摘されている。
従って、上述の如き抗カビ性、防ダニ性を繊維に付与
し、繊維本来の吸水性、保湿性、風合いを保持し実用上
充分な性能と安全性を有する繊維は開発されていないの
が現状である。
[0006] Regarding mite prevention, acaricides and repellents are fixed to fibers, but the durability of the effect and the safety to the human body have been pointed out.
Therefore, fibers that impart antifungal properties and anti-mite properties to the fibers as described above, retain the inherent water absorption, moisture retention, and texture of the fibers and have practically sufficient performance and safety have not been developed. It is.

【0007】[0007]

【発明が解決しようとする課題】本発明は、繊維自体が
本来有する吸水性、風合い等の性能を損なうことなく、
優れた保湿性を有し、抗菌性、抗カビ性、防ダニ性を併
せ具備する抗菌性セルロース再生繊維を提供するもので
ある。
DISCLOSURE OF THE INVENTION The present invention provides a fiber without impairing its inherent properties such as water absorption and texture.
An object of the present invention is to provide an antibacterial regenerated cellulose fiber having excellent moisturizing properties and having antibacterial properties, antifungal properties and anti-mite properties.

【0008】[0008]

【課題を解決するための手段】本発明者等はかかる課題
を解決すべく鋭意検討した結果、本発明に到達した。即
ち本発明は、粒子径10μm以下の再生キトサン微小粒
状体、又は再生アセチル化キトサン微小粒状体、ニトリ
ル系抗菌剤、ピリジン系抗菌剤、ハロアルキルチオ系抗
菌剤、有機ヨード系抗菌剤、チアゾール系抗菌剤、及び
ベンツイミダゾール系抗菌剤をセルロースビスコースに
添加し、該ビスコースを紡糸した抗菌性セルロース再生
繊維である。本発明の繊維は、これら複数の薬剤を同時
に混合含有していることで抗菌、抗カビ効果の相乗効果
が認められ、それぞれの薬剤が有している単独の効果以
上に幅広い抗菌スペクトル、幅広い抗カビスペクトル、
防ダニ性を発現することが可能である。
Means for Solving the Problems The present inventors have made intensive studies in order to solve the above problems, and as a result, have reached the present invention. That is, the present invention provides a regenerated chitosan microparticle having a particle diameter of 10 μm or less, or a regenerated acetylated chitosan microparticle, a nitrile antibacterial agent, a pyridine antibacterial agent, a haloalkylthio antibacterial agent, an organic iodine antibacterial agent, and a thiazole antibacterial agent. And a benzimidazole-based antibacterial agent added to cellulose viscose, and the viscose is spun to obtain an antibacterial cellulose regenerated fiber. The fiber of the present invention has a synergistic effect of antibacterial and antifungal effects by simultaneously mixing and containing these multiple drugs, and has a broader antibacterial spectrum and broader antibacterial effect than the individual effects of each drug. Mold spectrum,
It is possible to develop anti-mite properties.

【0009】[0009]

【発明の実施の形態】本発明に用いられる粒子径が10
μm以下の再生キトサン微小粒状体、又は再生アセチル
化キトサン微小粒状体を得るには、本出願人が特開昭6
2ー62827号公報及び特開昭62−100534号
公報に開示した方法によって作ることが好ましい。即
ち、キトサンを酸性水溶液に溶解してキトサン酸性水溶
液とし、該水溶液を塩基性水溶液中に落下等の手段で加
え凝固再生させ再生キトサンとし、又は、該再生キトサ
ンをメタノール、エタノール等の極性溶媒中で無水酢酸
等でアセチル化した再生アセチル化キトサンを、それぞ
れ中性になるまで十分水洗した後、該再生キトサン又は
再生アセチル化キトサンを更に微粒化することによっ
て、再生キトサン微小粒状体又は再生アセチル化キトサ
ン微小粒状体が効率よく得られる。
BEST MODE FOR CARRYING OUT THE INVENTION The particle size used in the present invention is 10
In order to obtain regenerated chitosan microparticles having a particle size of μm or less or regenerated acetylated chitosan microparticles, the present applicant has disclosed in
It is preferably prepared by the method disclosed in JP-A-2-62827 and JP-A-62-100534. That is, chitosan is dissolved in an acidic aqueous solution to obtain a chitosan acidic aqueous solution, and the aqueous solution is added to a basic aqueous solution by means of dropping or the like to coagulate and regenerate to obtain regenerated chitosan, or the regenerated chitosan is dissolved in a polar solvent such as methanol or ethanol. The regenerated acetylated chitosan acetylated with acetic anhydride or the like is thoroughly washed with water until it becomes neutral, and then the regenerated chitosan or the regenerated acetylated chitosan is further atomized, whereby the regenerated chitosan microparticles or regenerated acetylated Chitosan microparticles can be obtained efficiently.

【0010】抗菌性の発現、繊維の保湿性の向上には、
キトサンの分子内アミノ基が大きく寄与するため、再生
キトサンをアセチル化して再生アセチル化キトサンにす
る際のアセチル化の程度は、アミノ基を20%程度残
す、即ち脱アセチル化度が20%を下らないようにする
ことが好ましい。
[0010] For the expression of antibacterial properties and the improvement of moisture retention of fibers,
Since the intramolecular amino group of chitosan greatly contributes, the degree of acetylation when acetylating regenerated chitosan into regenerated acetylated chitosan leaves about 20% of amino groups, that is, the degree of deacetylation does not fall below 20%. It is preferable to do so.

【0011】尚、微粒化には、通常の噴霧乾燥機を使用
することが出来る。噴霧乾燥して微粒化するには、ホモ
ジナイザー等通常の湿式粉砕機で予め粉砕分散せしめ
て、平均粒径を50μm以下にした乳状の懸濁液として
用いるのがよい。このようにして得た懸濁液は、ノズル
の周辺から吐出される加圧空気と共に高温雰囲気中に吐
出乾燥されるが、この際収縮により更に微粒化される。
高温雰囲気中の温度は、被乾燥物が乾燥されるに充分な
温度であればよく100〜180℃の範囲で自由に選択
できる。得られる微粒子の粒子径は、高温雰囲気中に吐
出する際の吐出量と加えた空気圧を適宜調節することに
よって、任意に調整することが出来るが、確実に所望の
均一な粒子径の乾燥物を得るためには更に分級すること
が好ましい。
For atomization, a usual spray dryer can be used. In order to atomize by spray-drying, it is preferred to use a conventional wet pulverizer such as a homogenizer, which is previously pulverized and dispersed to use as a milky suspension having an average particle diameter of 50 μm or less. The suspension thus obtained is discharged and dried in a high-temperature atmosphere together with pressurized air discharged from the periphery of the nozzle. At this time, the suspension is further atomized by shrinkage.
The temperature in the high-temperature atmosphere may be any temperature as long as it is sufficient to dry the object to be dried, and can be freely selected in the range of 100 to 180 ° C. The particle size of the obtained fine particles can be arbitrarily adjusted by appropriately adjusting the discharge amount and the applied air pressure when discharging into a high-temperature atmosphere, but it is possible to surely obtain a dried product having a desired uniform particle size. It is preferable to further classify to obtain.

【0012】本発明に用いられるニトリル系抗菌剤とし
て好ましくは、ハロアリールニトリル化合物、より好ま
しくはハロイソフタロニトリル化合物が挙げられる。ハ
ロイソフタロニトリル化合物としては、2、4、5、6
−テトラクロロイソフタロニトリル、5−クロロ−2、
4、6−トリフロロイソフタロニトリル等を挙げること
が出来る。
The nitrile antibacterial used in the present invention is preferably a haloaryl nitrile compound, more preferably a haloisophthalonitrile compound. As the haloisophthalonitrile compound, 2, 4, 5, 6
-Tetrachloroisophthalonitrile, 5-chloro-2,
4,6-trifluoroisophthalonitrile and the like can be mentioned.

【0013】本発明に用いられるピリジン系抗菌剤とし
て好ましくは、ハロゲン化されたピリジン誘導体、ピリ
ジンチオール−1−オキシド化合物等が挙げられ、より
好ましくは、スルフォニルハロピリジン化合物、ピリジ
ンチオール−1−オキシド化合物等が挙げられる。
The pyridine antibacterial agent used in the present invention is preferably a halogenated pyridine derivative, a pyridinethiol-1-oxide compound or the like, and more preferably a sulfonylhalopyridine compound, a pyridinethiol-1-oxide compound. And the like.

【0014】上記ハロゲン化されたピリジン誘導体とし
ては、2−クロロ−6−トリクロロメチルピリジン、2
−クロロ−4−トリクロロメチル−6−メトキシピリジ
ン、2−クロロ−4−トリクロロメチル−6−(2−フ
リルメトキシ)ピリジン、ジ(4−クロロフェニル)ピ
リジルメタノールや、スルフォニルハロピリジン化合物
に分類される、2、3、5、6−テトラクロロ−4−メ
チルスルフォニルピリジン、2、3、5−トリクロロ−
4−(n−プロピルスルフォニル)ピリジン等が挙げら
れ、ピリジンチオール−1−オキシド化合物としては、
2−ピリジンチオール−1−オキシドナトリウム、2−
ピリジンチオール−1−オキシド亜鉛、ジ(2−ピリジ
ンチオール−1−オキシド)等が挙げられる。
Examples of the halogenated pyridine derivative include 2-chloro-6-trichloromethylpyridine,
-Chloro-4-trichloromethyl-6-methoxypyridine, 2-chloro-4-trichloromethyl-6- (2-furylmethoxy) pyridine, di (4-chlorophenyl) pyridylmethanol, and sulfonylhalopyridine compounds 2,2,5,6-tetrachloro-4-methylsulfonylpyridine, 2,3,5-trichloro-
4- (n-propylsulfonyl) pyridine and the like, and as the pyridinethiol-1-oxide compound,
2-pyridinethiol-1-oxide sodium, 2-
Pyridinethiol-1-oxide zinc, di (2-pyridinethiol-1-oxide) and the like can be mentioned.

【0015】本発明に用いられるハロアルキルチオ系抗
菌剤として好ましくは、ハロアルキルチオフタルイミド
化合物、ハロアルキルチオテトラヒドロフタルイミド化
合物、ハロアルキルチオスルファミド化合物、ハロアル
キルチオスルフィミド化合物等を挙げることが出来る。
Preferred examples of the haloalkylthio antibacterial agent used in the present invention include haloalkylthiophthalimide compounds, haloalkylthiotetrahydrophthalimide compounds, haloalkylthiosulfamide compounds, haloalkylthiosulfimide compounds and the like.

【0016】上記ハロアルキルチオフタルイミド化合物
としては、N−フロロジクロロメチルチオフタルイミ
ド、N−トリクロロメチルチオフタルイミド等が挙げら
れ、ハロアルキルチオテトラヒドロフタルイミド化合物
としては、N−1、1、2、2−テトラクロロエチルチ
オテトラヒドロフタルイミド、N−トリクロロメチルチ
オテトラヒドロフタルイミド等を挙げることが出来る。
Examples of the haloalkylthiophthalimide compound include N-fluorodichloromethylthiophthalimide and N-trichloromethylthiophthalimide, and examples of the haloalkylthiotetrahydrophthalimide compound include N-1,1,2,2-tetrachloroethylthiotetrahydrophthalimide. , N-trichloromethylthiotetrahydrophthalimide and the like.

【0017】また、ハロアルキルチオスルファミド化合
物としては、N−トリクロロメチルチオ−N−(フェニ
ル)メチルスルファミド、N−トリクロロメチルチオ−
N−(4−クロロフェニル)メチルスルファミド、N−
(1−フロロ−1、1、2、2−テトラクロロエチルチ
オ)−N−(フェニル)メチルスルファミド、N−
(1、1−ジフロロ−1、2、2−トリクロロエチルチ
オ)−N−(フェニル)メチルスルファミド等が挙げら
れ、ハロアルキルチオスルフィミド化合物としては、
N、N−ジメチル−N´−フェニル−N´−(フロロジ
クロロメチルチオ)スルフィミド、N、N−ジクロロフ
ロロメチルチオ−N´−フェニルスルフィミド、N、N
−ジメチル−N´−(p−トリル)−N´−(フロロジ
クロロメチルチオ)スルフィミド等を挙げることが出来
る。
The haloalkylthiosulfamide compounds include N-trichloromethylthio-N- (phenyl) methylsulfamide, N-trichloromethylthio-
N- (4-chlorophenyl) methylsulfamide, N-
(1-fluoro-1,1,2,2-tetrachloroethylthio) -N- (phenyl) methylsulfamide, N-
(1,1-difluoro-1,2,2-trichloroethylthio) -N- (phenyl) methylsulfamide and the like, and as the haloalkylthiosulfimide compound,
N, N-dimethyl-N'-phenyl-N '-(fluorodichloromethylthio) sulfimide, N, N-dichlorofluoromethylthio-N'-phenylsulfimide, N, N
-Dimethyl-N '-(p-tolyl) -N'-(florodichloromethylthio) sulfimide.

【0018】本発明に用いられる有機ヨード系抗菌剤と
しては好ましくは、ヨードスルフォン化合物、ヨウ化不
飽和脂肪族化合物等が挙げられ、より好ましくは、ヨー
ドスルフォニルベンゼン化合物を挙げることが出来る。
As the organic iodine antibacterial agent used in the present invention, preferably, an iodosulfone compound, an iodide unsaturated aliphatic compound and the like are mentioned, and more preferably, an iodosulfonylbenzene compound can be mentioned.

【0019】上記ヨードスルフォニル化合物としては、
ヨードスルフォニルベンゼン化合物である、ジヨードメ
チル−p−トリルスルフォン、1−ジヨードメチルスル
フォニル−4−メチルベンゼン、1−ジヨードメチルス
ルフォニル−4−クロロベンゼン等が挙げられ、また、
ヨウ化不飽和脂肪族化合物としては、3−ヨード−2−
プロパルギルブチルカルバミン酸、4−クロロフェニル
−3−ヨードプロパルギルホルマール、3−エトキシカ
ルボニルオキシ−1−ブロム−1、2−ジヨード−1−
プロペン、2、3、3−トリヨードアリルアルコール等
を挙げることが出来る。
The iodosulfonyl compound includes:
Iodosulfonylbenzene compounds such as diiodomethyl-p-tolylsulfone, 1-diiodomethylsulfonyl-4-methylbenzene, 1-diiodomethylsulfonyl-4-chlorobenzene, and the like;
As the iodinated unsaturated aliphatic compound, 3-iodo-2-
Propargyl butylcarbamic acid, 4-chlorophenyl-3-iodopropargyl formal, 3-ethoxycarbonyloxy-1-bromo-1,2-diiodo-1-
Propene, 2,3,3-triiodoallyl alcohol and the like can be mentioned.

【0020】本発明に用いられるチアゾール系抗菌剤と
して好ましくは、イソチアゾリン−3−オン化合物、ベ
ンツチアゾール化合物等が挙げられ、より好ましくは、
イソチアゾリン−3−オン化合物等を挙げることが出来
る。
Preferred examples of the thiazole antibacterial agent used in the present invention include an isothiazolin-3-one compound and a benzthiazole compound.
An isothiazolin-3-one compound can be exemplified.

【0021】上記イソチアゾリン−3−オン化合物とし
ては、1、2−ベンツイソチアゾリン−3−オン、2−
(n−オクチル)−4−イソチアゾリン−3−オン、5
−クロロ−2−メチル−4−イソチアゾリン−3−オ
ン、2−メチル−4−イソチアゾリン−3−オン、4、
5−ジクロロ−2−シクロヘキシル−4−イソチアゾリ
ン−3−オン等が挙げられ、ベンツチアゾール化合物と
しては、2−(4−チオシアノメチルチオ)ベンツチア
ゾール、2−メルカプトベンツチアゾールナトリウム、
2−メルカプトベンツチアゾール亜鉛等を挙げることが
出来る。
The above isothiazolin-3-one compounds include 1,2-benzisothiazolin-3-one,
(N-octyl) -4-isothiazolin-3-one, 5
-Chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one, 4,
5-dichloro-2-cyclohexyl-4-isothiazolin-3-one and the like. Examples of the benzthiazole compound include 2- (4-thiocyanomethylthio) benzthiazole, 2-mercaptobenzthiazole sodium,
Zinc 2-mercaptobenzthiazole and the like can be mentioned.

【0022】本発明に用いられるベンツイミダゾール系
抗菌剤として好ましくは、ベンツイミダゾールカルバミ
ン酸化合物、イオウ原子含有ベンツイミダゾール化合
物、ベンツイミダゾールの環式化合物誘導体等を挙げる
ことが出来、より好ましくは、ベンツイミダゾールカル
バミン酸化合物、チアゾリルベンツイミダゾール化合物
等が挙げられる。
The benzimidazole antibacterial agent used in the present invention is preferably a benzimidazole carbamic acid compound, a sulfur atom-containing benzimidazole compound, a cyclic compound derivative of benzimidazole, or the like, and more preferably benzimidazole. Carbamic acid compounds, thiazolylbenzimidazole compounds and the like.

【0023】上記ベンツイミダゾールカルバミン酸化合
物としては、1H−2−ベンツイミダゾールカルバミン
酸メチル、1−ブチルカルバモイル−2−ベンツイミダ
ゾールカルバミン酸メチル、6−ベンゾイル−1H−2
−ベンツイミダゾールカルバミン酸メチル、6−(2−
チオフェンカルボニル)−1H−2−ベンツイミダゾー
ルカルバミン酸メチル等が挙げられる。
The above-mentioned benzimidazole carbamate compounds include methyl 1H-2-benzimidazole carbamate, 1-butylcarbamoyl-2-methyl benzimidazole carbamate and 6-benzoyl-1H-2.
-Methyl benzimidazole carbamate, 6- (2-
Thiophenecarbonyl) -1H-2-benzimidazole methyl carbamate and the like.

【0024】また、イオウ原子含有ベンツイミダゾール
化合物としては、1H−2−チオシアノメチルチオベン
ツイミダゾール、1−ジメチルアミノスルフォニル−2
−シアノ−4−ブロモ−6−トリフロロメチルベンツイ
ミダゾール等を挙げることが出来る。
The sulfur atom-containing benzimidazole compounds include 1H-2-thiocyanomethylthiobenzimidazole and 1-dimethylaminosulfonyl-2.
-Cyano-4-bromo-6-trifluoromethylbenzimidazole and the like.

【0025】ベンツイミダゾールの環式化合物誘導体と
しては、2−(4−チアゾリル)−1H−ベンツイミダ
ゾール、2−(2−クロロフェニル)−1H−ベンツイ
ミダゾール、2−(1−(3、5−ジメチルピラゾリ
ル))−1H−ベンツイミダゾール、2−(2−フリ
ル)−1H−ベンツイミダゾール等が挙げられる。
The cyclic compound derivatives of benzimidazole include 2- (4-thiazolyl) -1H-benzimidazole, 2- (2-chlorophenyl) -1H-benzimidazole, 2- (1- (3,5-dimethyl) Pyrazolyl))-1H-benzimidazole, 2- (2-furyl) -1H-benzimidazole and the like.

【0026】上記ニトリル系抗菌剤、ピリジン系抗菌
剤、ハロアルキルチオ系抗菌剤、有機ヨード系抗菌剤、
チアゾール系抗菌剤、ベンツイミダゾール系抗菌剤は、
それぞれの抗菌剤より1種又は2種以上を選択し混合し
て用いても良い。また、上述に記載の6種類の抗菌剤の
1種類でも欠けていると期待される効果が発揮されな
い。選ばれた抗菌剤を混合した混合物の粒子径は再生キ
トサン微小粒状体又は再生アセチル化キトサン微小粒状
体と同様に紡糸時の口金詰まりを防止するために10μ
m以下が好ましい。10μm以下に調整する方法として
は、10μm以下に粉砕機等により微粉砕した個々の抗
菌剤粒子を混合する方法、それぞれの抗菌剤を混合した
後に微粉砕する方法等があるが、何れの方法を用いても
良い。
The above nitrile antibacterial agent, pyridine antibacterial agent, haloalkylthio antibacterial agent, organic iodine antibacterial agent,
Thiazole antibacterial agents, benzimidazole antibacterial agents,
One or two or more of these antibacterial agents may be selected and used as a mixture. Further, even one of the six antibacterial agents described above does not exhibit the effect expected to be lacking. The particle size of the mixture obtained by mixing the selected antibacterial agents is 10 μm in order to prevent clogging during spinning as in the case of the regenerated chitosan microparticles or regenerated acetylated chitosan microparticles.
m or less is preferable. As a method of adjusting the particle size to 10 μm or less, there is a method of mixing individual antibacterial agent particles finely pulverized with a pulverizer or the like to 10 μm or less, a method of pulverizing after mixing each antibacterial agent, and the like. May be used.

【0027】次に、このようにして得た粒子径10μm
以下の再生キトサン微小粒状体又は再生アセチル化キト
サン微小粒状体とニトリル系抗菌剤、ピリジン系抗菌
剤、ハロアルキルチオ系抗菌剤、有機ヨード系抗菌剤、
チアゾール系抗菌剤、ベンツイミダゾール系抗菌剤をセ
ルロース再生繊維に同時に含有させるには、そのままか
又は、予め水又はアルカリ水溶液に分散させて添加溶液
とするか、あるいは添加させる適量のセルロースビスコ
ース中に分散させて添加溶液とし、紡糸直前にセルロー
スビスコースと混合して紡糸すればよい。この時の紡糸
条件等は、通常のセルロース再生繊維の製造条件が適用
される。また、本発明で用いられるセルロースビスコー
スは、通常レーヨンビスコースとポリノジックビスコー
スがあり、本発明の抗菌性セルロース再生繊維は、ステ
ープル、フィラメント等の如何なる形状でもよく、繊度
にも制限なくまた、ダル化等のため酸化チタン等の無機
顔料を共に用いることもできる。
Next, the thus obtained particle diameter of 10 μm
The following regenerated chitosan microparticles or regenerated acetylated chitosan microparticles and nitrile antibacterial agents, pyridine antibacterial agents, haloalkylthio antibacterial agents, organic iodine antibacterial agents,
In order to simultaneously contain the thiazole antibacterial agent and the benzimidazole antibacterial agent in the cellulose regenerated fiber, as it is, or as an additional solution previously dispersed in water or an alkaline aqueous solution, or in an appropriate amount of cellulose viscose to be added What is necessary is just to disperse it into an additive solution, mix it with cellulose viscose just before spinning, and spin it. As for the spinning conditions and the like at this time, ordinary production conditions for regenerated cellulose fibers are applied. The cellulose viscose used in the present invention generally has rayon viscose and polynosic viscose, and the antibacterial cellulose regenerated fiber of the present invention may have any shape such as staples and filaments. An inorganic pigment such as titanium oxide can be used together for dulling or the like.

【0028】粒子形10μm以下の再生キトサン微小粒
状体又は再生アセチル化キトサン微小粒状体とニトリル
系抗菌剤、ピリジン系抗菌剤、ハロアルキルチオ系抗菌
剤、有機ヨード系抗菌剤、チアゾール系抗菌剤、ベンツ
イミダゾール系抗菌剤の合計の対セルロース添加量は、
0.3〜2.0重量%が好ましい。添加量が少ないと所
望の抗菌性や抗カビ性が得られず、添加量が多いと繊維
強度が低下し、実用上不適である。
Regenerated chitosan microparticles having a particle size of 10 μm or less or regenerated acetylated chitosan microparticles and nitrile antibacterial agents, pyridine antibacterial agents, haloalkylthio antibacterial agents, organic iodine antibacterial agents, thiazole antibacterial agents, benz The total amount of imidazole antibacterial agent added to cellulose is
0.3 to 2.0% by weight is preferred. If the amount is small, the desired antibacterial and antifungal properties cannot be obtained, and if the amount is large, the fiber strength decreases, which is not suitable for practical use.

【0029】再生キトサン微小粒状体又は再生アセチル
化キトサン微小粒状体と抗菌剤を混合した混合物中に占
める再生キトサン微小粒状体又は再生アセチル化キトサ
ン微小粒状体の割合は、10〜90%が好ましい。10
%より少ない場合には充分な抗菌性と繊維の保湿性が得
られず、90%より多い場合には所望の抗カビ性、防ダ
ニ性が得られない。従ってより好ましくは再生キトサン
微小粒状体又は再生アセチル化キトサン微小粒状体の割
合は20〜80%である。実施例からも明らかな如く、
再生キトサン微小粒状体、又は再生アセチル化キトサン
微小粒状体を加えず抗菌剤の混合物のみを含有させたも
のでは本願発明の効果は期待できず、本発明の抗菌性セ
ルロース再生繊維では、上述の構成であることから繊維
本来の吸水性があり、優れた保湿性があり、従来の抗菌
性セルロース再生繊維には見られなかった抗菌性、抗カ
ビ性、防ダニ性を同時に具備している。
The proportion of the regenerated chitosan microparticles or the regenerated acetylated chitosan microparticles in the mixture of the regenerated chitosan microparticles or the regenerated acetylated chitosan microparticles and the antibacterial agent is preferably 10 to 90%. 10
If it is less than 90%, sufficient antibacterial properties and fiber moisturizing properties cannot be obtained, and if it is more than 90%, desired antifungal properties and anti-mite properties cannot be obtained. Therefore, more preferably, the ratio of the regenerated chitosan microparticles or the regenerated acetylated chitosan microparticles is 20 to 80%. As is clear from the examples,
Regenerated chitosan microparticles, or those containing only a mixture of antibacterial agents without adding regenerated acetylated chitosan microparticles, the effect of the present invention cannot be expected, and the antibacterial cellulose regenerated fiber of the present invention has the above-described structure. As a result, the fiber has the inherent water absorbency, excellent moisture retention, and simultaneously has antibacterial properties, antifungal properties, and anti-mite properties not found in conventional antibacterial cellulose regenerated fibers.

【0030】[0030]

【実施例】以下、本発明の実施例について具体的に説明
するが、本発明はこの範囲に限定されるものではない。
また、繊度、乾強度、湿強度、結節強度、吸湿性、抗菌
性能、抗カビ性能、防ダニ性能等は以下の方法で試験し
た。 (1)繊度、乾強度、湿強度、結節強度 JIS L 1015 「化学繊維のステープル試験
法」 (2)吸湿性 試料約10gの絶乾重量を測定し、直ちに35℃、相対
湿度90%の環境下に60分間放置し、その重量を測定
し、重量変化より水分率を求め吸湿性とした。 (3)抗菌性能 繊維製品衛生加工協議会の、抗菌加工製品加工効果試験
マニュアルの、菌数測定法に準じて抗菌性能を測定し
た。その方法は次の通りである。
EXAMPLES Examples of the present invention will be specifically described below, but the present invention is not limited to this range.
The fineness, dry strength, wet strength, knot strength, hygroscopicity, antibacterial performance, antifungal performance, anti-mite performance, etc. were tested by the following methods. (1) Fineness, dry strength, wet strength, knot strength JIS L 1015 “Staple test method for chemical fibers” (2) Hygroscopicity Approximately 10 g of absolute dry weight of a sample is measured, and immediately measured at 35 ° C. and 90% relative humidity. The sample was allowed to stand for 60 minutes, and its weight was measured. (3) Antibacterial performance The antibacterial performance was measured according to the method for measuring the number of bacteria in the Antibacterial Product Processing Effect Test Manual of the Textile Sanitary Processing Council. The method is as follows.

【0031】〈菌数測定法〉黄色ブドウ球菌(Staphylo
coccus aureus, IFO 12732,以下表中ではS.と示
す)、大腸菌(Escherichia coli, IFO 13168 ,以下表
中ではE.と示す)、緑膿菌(Pseudomonas aeruginos
a, IFO 3080,以下表中ではP.と示す)を試験菌体と
し、これを予め普通ブイヨン培地で5〜30×105
/mlとなるよう培養調整し試験菌懸濁液とする。該懸
濁液0.2mlを滅菌処理をしたネジ付きバイアル瓶中
の試料0.2gに均一に接種し、35〜37℃、18時
間静置培養後、容器中に滅菌緩衡生理食塩液を20ml
加え、手で振幅約30cmで25〜30回強く振盪して
試験中の生菌を液中に分散させた後、滅菌緩衡生理食塩
液で適当な希釈系列を作り、各段階の希釈液1mlを各
々滅菌シャーレに入れ標準寒天培地の約15ml混釈平
板を同一希釈液に付き各2枚ずつ作成した。これを35
〜37℃で24時間培養後、生育コロニー数を計測し、
その希釈倍率を乗じて試料中の生菌数を算出した。
<Bacterial Counting Method> Staphylo
coccus aureus, IFO 12732; Escherichia coli, IFO 13168, and E. in the following table), Pseudomonas aeruginos
a, IFO 3080; ) Is used as a test cell, and this is preliminarily cultured in a normal broth medium at 5 to 30 × 10 5 cells / ml to prepare a test cell suspension. 0.2 ml of the suspension is uniformly inoculated to 0.2 g of a sample in a sterilized screw vial, and cultured at 35 to 37 ° C. for 18 hours, and then sterilized buffered saline is added to the container. 20ml
In addition, after vigorously shaking by hand 25 to 30 times with an amplitude of about 30 cm to disperse the viable bacteria under test in the solution, make an appropriate dilution series with sterile buffered saline, and dilute 1 ml of each stage. Was placed in a sterile petri dish, and about 15 ml of a standard agar medium pour plate was attached to the same diluent to prepare two plates each. This is 35
After culturing at ~ 37 ° C for 24 hours, the number of growing colonies was counted,
The number of viable bacteria in the sample was calculated by multiplying the dilution factor.

【0032】そして、その効果の判定は、再生キトサン
微小粒状体又は再生アセチル化キトサン微小粒状体とニ
トリル系抗菌剤,ピリジン系抗菌剤,ハロアルキルチオ
系抗菌剤,有機ヨード系抗菌剤,チアゾール系抗菌剤,
ベンツイミダゾール系抗菌剤の無添加試料3検体と添加
試料3検体の平均菌数を基に次式で増減値差を求め、
1.6以上を抗菌効果ありと判定した。
The effect is determined by comparing the regenerated chitosan microparticles or regenerated acetylated chitosan microparticles with a nitrile antibacterial agent, a pyridine antibacterial agent, a haloalkylthio antibacterial agent, an organic iodine antibacterial agent, and a thiazole antibacterial agent. Agent,
Based on the average number of bacteria of three samples without addition of the benzimidazole antibacterial agent and three samples of the addition sample, the difference between the increase and decrease was calculated by the following formula,
1.6 or more was determined to have an antibacterial effect.

【0033】[0033]

【数1】 (Equation 1)

【0034】(4)抗カビ性能 JIS Z 2911 「カビ抵抗性試験」 湿式試験
法 尚、試験菌体はアスペルギルス・ニゲル(Aspergillus
niger,IFO 4414,以下表中ではA.と示す)、ケトミウ
ム・グロボサム(Chaetomium globosum,IFO 6347,以下
表中ではC.と示す)、トリコデルマ・ビリデ(Tricho
derma viride,IFO 5720 ,以下表中ではT.と示す)の
3種類を用いた。結果は、次に示すカビ抵抗性の表示に
より判定した。
(4) Antifungal performance JIS Z 2911 "Mold resistance test" Wet test method The test cells were Aspergillus niger (Aspergillus niger)
niger, IFO 4414; ), Ketomium globosum (IFO 6347, hereinafter referred to as C.), Trichoderma viride (Tricho)
derma viride, IFO 5720; ) Were used. The results were determined by the following indication of mold resistance.

【0035】[0035]

【表1】 [Table 1]

【0036】(5)防ダニ性能 直径4cm、高さ0.6cmのプラスチック製シャーレの底
面一面に均一に試料を敷き混みこの上にダニの入ってい
ない粉末飼料0.05gを置く。これを直径9cm、高さ
1.5cmのプラスチック製シャーレの中央に置く。この
大小のシャーレの間に、良く繁殖したダニ培地を生存ダ
ニ数として約3,000個体投入し、均一に広げる。こ
れを粘着シート上に置き、27×13×9cmの食品保存
用プラスチック製容器に粘着シートごと入れ、飽和食塩
水を入れて蓋をして容器内の湿度を約75%に保ち、2
5℃±1℃の恒温器に格納して1昼夜飼育の後、試料か
ら水洗い法にてダニを回収の後計数し、次式に当てはめ
て忌避率を求めた。なお、試験はばらつきを考慮し、3
回の繰り返しを行った。
(5) Mite-preventing performance A sample is uniformly spread over the entire bottom surface of a plastic petri dish having a diameter of 4 cm and a height of 0.6 cm, and 0.05 g of a powder feed free of mites is placed on the sample. This is placed in the center of a plastic petri dish having a diameter of 9 cm and a height of 1.5 cm. Between these large and small petri dishes, approximately 3,000 viable mite culture media are introduced as the number of viable mites and spread uniformly. Put this on an adhesive sheet, put the adhesive sheet together in a 27 × 13 × 9 cm plastic container for food preservation, put saturated saline solution, cover the container and keep the humidity in the container at about 75%,
After being stored in a thermostat at 5 ° C. ± 1 ° C. and bred for one day and night, the mites were collected from the sample by a water washing method, counted, and the repellency was determined by applying the following formula. In addition, the test considered the variation and
Times.

【0037】[0037]

【数2】 (Equation 2)

【0038】〔実施例1〕脱アセチル化度85%平均分
子量42,000のキトサン500gを、酢酸250g
を含む水7,750gに加えて溶解しキトサン酢酸水溶
液を得た。この溶液の20℃に於ける粘度は、回転粘度
計で測定したところ、3,400cps であった。このキ
トサン酸性水溶液を5%苛性ソーダ水溶液中に落下させ
て、粒状に凝固再生させた。
Example 1 Deacetylation degree 85% 500 g of chitosan having an average molecular weight of 42,000 was added to 250 g of acetic acid.
Was added to and dissolved in 7,750 g of water to obtain an aqueous solution of chitosan acetic acid. The viscosity of this solution at 20 ° C. was 3,400 cps as measured by a rotational viscometer. The acidic aqueous solution of chitosan was dropped into a 5% aqueous solution of caustic soda to solidify and regenerate in granular form.

【0039】この凝固物を中性になるまで十分水で洗浄
した後、予め最終固形分濃度が2〜2.5%になるよう
に水を加えて、15,000rpm の回転数で3分間ずつ
3回繰り返して粉砕分散させ乳状の懸濁液とした。これ
を120メッシュの篩で粗大片を濾別し、攪拌機で攪拌
しながら、濾液を3.0kg/cm2 の加圧空気と共に毎分
18mlの流量で、170〜180℃の高温雰囲気中に
吐出して乾燥し、乾燥物をサイクロンコレクターに捕集
した。該乾燥物を風力分級機((株)セイシン企業製、
商品名スペディック250)を用いて、分級して粒子径
5μm以下の再生キトサン微小粒状体300gを得た。
After washing the coagulated product sufficiently with water until it becomes neutral, water is added in advance so that the final solid content concentration becomes 2 to 2.5%, and the mixture is rotated at 15,000 rpm for 3 minutes. The mixture was pulverized and dispersed three times to obtain a milky suspension. This was filtered through a 120-mesh sieve to remove coarse pieces, and the filtrate was discharged into a high-temperature atmosphere at 170 to 180 ° C at a flow rate of 18 ml / min with pressurized air of 3.0 kg / cm 2 while stirring with a stirrer. The dried product was collected in a cyclone collector. The dried product is classified into an air classifier (manufactured by Seishin Enterprise Co., Ltd.)
Classification was performed using a trade name (Specdik 250) to obtain 300 g of regenerated chitosan fine granules having a particle size of 5 μm or less.

【0040】この再生キトサン微小粒状体に対して、ニ
トリル系抗菌剤,ピリジン系抗菌剤,ハロアキルチオ系
抗菌剤,有機ヨード系抗菌剤,チアゾール系抗菌剤,ベ
ンツイミダゾール系抗菌剤の混合物である市販の抗菌抗
黴剤((株)センカワ製、商品名K・B・9 E,以下
抗菌抗黴剤Aと略記する)を再生キトサン微小粒状体対
抗菌抗黴剤Aが80対20(重量比)となるように添加
混合し、再生キトサン微小粒状体と抗菌抗黴剤Aの混合
物375gを得た。
A commercially available mixture of a nitrile-based antibacterial agent, a pyridine-based antibacterial agent, a haloalkylthio-based antibacterial agent, an organic iodine-based antibacterial agent, a thiazole-based antibacterial agent, and a benzimidazole-based antibacterial agent is applied to the regenerated chitosan microparticles. Regenerated antibacterial and antifungal agent (manufactured by SENKAWA Co., Ltd., trade name KB9E, hereinafter abbreviated as antibacterial and antifungal agent A) 80 to 20 (weight ratio) of chitosan microparticles to antibacterial and antifungal agent A And 375 g of a mixture of the regenerated chitosan microparticles and the antibacterial antifungal agent A was obtained.

【0041】この再生キトサン微小粒状体と抗菌抗黴剤
Aの混合物を、従来法によって得られたレーヨンビスコ
ース(セルロース9.0%、全アルカリ6.0%、全硫
黄2.5%)各15リットルに、セルロースに対し、
0,0.3,0.5,2.0,3.0重量%の添加量に
なるように予め水に分散させておいた再生キトサン微小
粒状体と抗菌抗黴剤A混合物分散液をそれぞれ添加し、
均一にレーヨンビスコースに混合し、脱泡後、直ちに
0.09mmφ×100Hのノズルを使用し、紡糸速度5
2m/分で、硫酸115g/l、硫酸ナトリウム310
g/l、硫酸亜鉛14g/l、温度53℃の紡糸浴に紡
糸し、通常の二浴緊張紡糸法により延伸し32mmに切断
後、通常の精練乾燥処理をして、3デニールの抗菌性セ
ルロース再生繊維をそれぞれ試料1〜5として糸切れな
く製造して得た。これらの試料1〜5の繊度,乾強度,
湿強度,結節強度,吸湿性を測定し、その結果を表2
に、抗菌性能,抗カビ性能,防ダニ性能の測定結果を表
3に示した。
A mixture of the regenerated chitosan microparticles and the antibacterial and antifungal agent A was mixed with rayon viscose (cellulose 9.0%, total alkali 6.0%, total sulfur 2.5%) obtained by a conventional method. 15 liters, for cellulose
The regenerated chitosan microparticles and the antibacterial and antifungal agent A mixture dispersion liquid, which were previously dispersed in water so as to be added amounts of 0, 0.3, 0.5, 2.0, and 3.0% by weight, respectively, were prepared. Add,
After uniformly mixing with rayon viscose and defoaming, immediately use a nozzle of 0.09 mmφ × 100H and spinning speed 5
At 2 m / min, sulfuric acid 115 g / l, sodium sulfate 310
g / l, zinc sulfate 14 g / l, spinning in a spinning bath at a temperature of 53 ° C., drawing by a conventional two-bath tension spinning method, cutting to 32 mm, and performing a usual scouring and drying treatment to obtain a 3-denier antibacterial cellulose. Recycled fibers were obtained as Samples 1 to 5 without breakage. The fineness, dry strength,
Table 2 shows the results of measuring the wet strength, knot strength and hygroscopicity.
Table 3 shows the measurement results of the antibacterial performance, the antifungal performance, and the anti-mite performance.

【0042】[0042]

【表2】 [Table 2]

【0043】[0043]

【表3】 [Table 3]

【0044】表2,表3から明らかなように、再生キト
サン微小粒状体と抗菌抗黴剤Aを同時にレーヨンビスコ
ースに添加し紡糸して得た抗菌性セルロース再生繊維は
優れた吸湿性を有すると共に、抗菌性能,抗カビ性能,
防ダニ性能を併せ具備しているが、試料5は優れた抗菌
性能,抗カビ性能,防ダニ性能を発現するものの強力低
下が大きい。従って、実用上再生キトサン微小粒状体と
抗菌抗黴剤Aの混合物の添加量はセルロースに対して
0.3〜2.0%が好ましい。
As is apparent from Tables 2 and 3, the regenerated antibacterial cellulose regenerated fiber obtained by simultaneously adding the regenerated chitosan microparticles and the antibacterial antifungal agent A to rayon viscose and spinning have excellent hygroscopicity. Along with antibacterial performance, antifungal performance,
Sample 5 has excellent antibacterial performance, antifungal performance, and mite prevention performance, but has a large decrease in strength. Therefore, in practice, the amount of the mixture of the regenerated chitosan microparticles and the antibacterial and antifungal agent A is preferably 0.3 to 2.0% based on cellulose.

【0045】〔実施例2〕脱アセチル化度90%、平均
分子量54,000のキトサン500gを250gの酢
酸を含む7,750gに溶解してキトサン酢酸水溶液を
得た。この溶液の20℃における粘度は回転粘度計で測
定したところ4,300cps であった。このキトサン酸
性溶液を5%のアンモニア水溶液中に落下させて、紐状
にキトサンを凝固再生させた。
Example 2 500 g of chitosan having a degree of deacetylation of 90% and an average molecular weight of 54,000 was dissolved in 7,750 g containing 250 g of acetic acid to obtain an aqueous solution of chitosan acetic acid. The viscosity at 20 ° C. of this solution was 4,300 cps as measured by a rotational viscometer. This chitosan acidic solution was dropped into a 5% aqueous ammonia solution to coagulate and regenerate chitosan in a string form.

【0046】この凝固物を中性になるまで十分水で洗浄
した後、実施例1と同様にホモジナイザーを用いて、1
5,000rpm の回転数で3分間ずつ3回繰り返し粉砕
分散させ乳状の懸濁液とした。これを100メッシュの
篩で濾過後、濾液を攪拌機で攪拌しで分散状態を保ちな
がら、4.0kg/cm2 の加圧空気と共に毎分16mlの
流量で、175℃の高温雰囲気中に吐出して乾燥し、乾
燥物をサイクロンコレクターに捕集した。該乾燥物を実
施例1と同様にして分級し、粒子径5μm以下の再生キ
トサン微小粒状体360gを得た。
After the coagulated product was sufficiently washed with water until it became neutral, the coagulated product was treated with a homogenizer in the same manner as in Example 1 to obtain 1
The mixture was pulverized and dispersed three times at 5,000 rpm for 3 minutes each to obtain a milky suspension. This was filtered through a 100-mesh sieve, and the filtrate was stirred with a stirrer and discharged into a 175 ° C. high temperature atmosphere at a flow rate of 16 ml / min together with 4.0 kg / cm 2 of pressurized air while maintaining a dispersed state. The dried product was collected by a cyclone collector. The dried product was classified in the same manner as in Example 1 to obtain 360 g of regenerated chitosan fine granules having a particle size of 5 μm or less.

【0047】この再生キトサン微小粒状体に対して、実
施例1で用いた市販の抗菌抗黴剤Aを再生キトサン微小
粒状体対抗菌抗黴剤Aが80対20(重量比)となるよ
うに添加し、再生キトサン微小粒状体と抗菌抗黴剤Aの
混合物450gを得た。
With respect to the regenerated chitosan microparticles, the commercially available antibacterial and antifungal agent A used in Example 1 was used so that the regenerated chitosan microparticles and the antibacterial antifungal agent A became 80 to 20 (weight ratio). The mixture was added to obtain 450 g of a mixture of the regenerated chitosan microparticles and the antibacterial antifungal agent A.

【0048】この再生キトサン微小粒状体と抗菌抗黴剤
Aの混合物を、ポリノジックビスコース(セルロース
5.0%、、全アルカリ3.5%、全硫黄3%)各15
リットルに、セルロースに対して、0,0.3,0.
5,2.0,3.0重量%の混合量になるように予め水
に分散させておいた再生キトサン微小粒状体と抗菌抗黴
剤A混合物分散液を添加し均一に混合し、脱泡後、直ち
に0.07mmφ×500Hのノズルを使用し、紡糸速度
32m/分で硫黄24g/l、硫酸亜鉛0.4g/l、
硫酸ナトリウム60g/l、温度35℃の紡糸浴に紡糸
し、次いで硫酸2g/l、硫酸亜鉛0.05g/l、温
度27℃の浴中で2倍延伸し38mmに切断した後、炭酸
ナトリウム1g/l、硫酸ナトリウム2g/l、温度6
0℃の条件で処理を行なった後、再度硫酸5g/l、温
度65℃で処理し、通常の精練、乾燥処理を行って、
1.25デニールの抗菌性セルロース再生繊維を糸切れ
なくそれぞれ試料6〜10として製造して得た。これら
の試料6〜10の繊度,乾強度,湿強度,結節強度,吸
湿性を測定し、その結果を表4に、抗菌性能,抗カビ性
能,防ダニ性能の測定結果を表5に示した。
A mixture of the regenerated chitosan microparticles and the antibacterial and antifungal agent A was mixed with polynosic viscose (cellulose 5.0%, total alkali 3.5%, total sulfur 3%) for each 15 parts.
Liters, 0,0.3,0.
A dispersion of the regenerated chitosan microparticles and the antibacterial and antifungal agent A mixture previously dispersed in water so as to have a mixing amount of 5, 2.0, and 3.0% by weight is added, and the mixture is uniformly mixed and defoamed. Immediately thereafter, using a nozzle of 0.07 mmφ × 500H, at a spinning speed of 32 m / min, 24 g / l of sulfur, 0.4 g / l of zinc sulfate,
The fiber is spun into a spinning bath of sodium sulfate 60 g / l at a temperature of 35 ° C., then stretched twice in a bath of 2 g / l sulfuric acid and 0.05 g / l of zinc sulfate at a temperature of 27 ° C., cut into 38 mm, and then cut into 1 g of sodium carbonate. / L, sodium sulfate 2g / l, temperature 6
After the treatment under the condition of 0 ° C., the treatment was again performed at 5 g / l of sulfuric acid and the temperature of 65 ° C., and the ordinary scouring and drying treatment was performed.
1.25-denier antibacterial cellulose regenerated fiber was produced as Samples 6 to 10 without thread breakage. The fineness, dry strength, wet strength, knot strength and hygroscopicity of these samples 6 to 10 were measured, and the results are shown in Table 4, and the measurement results of antibacterial performance, antifungal performance and mite prevention performance are shown in Table 5. .

【0049】[0049]

【表4】 [Table 4]

【0050】[0050]

【表5】 [Table 5]

【0051】表4,表5から明らかなように、キトサン
微小粒状体と抗菌抗黴剤Aを同時にポリノジックビスコ
ースに添加し紡糸して得たポリノジックの抗菌性セルロ
ース再生繊維は優れた吸湿性を有すると共に、抗菌性
能,抗カビ性能,防ダニ性能を併せ具備しているが、試
料10は優れた抗菌性能,抗カビ性能,防ダニ性能を発
現するものの強力低下が大きい。従って、実用上再生キ
トサン微小粒状体と抗菌抗黴剤Aの混合物の添加量はセ
ルロースに対して0.3〜2.0%が好ましい。
As is clear from Tables 4 and 5, the antibacterial cellulose regenerated fiber of polynosic obtained by simultaneously adding the chitosan microparticles and the antibacterial and antifungal agent A to the polynosic viscose and spinning the fiber has excellent hygroscopicity. In addition to having the antibacterial performance, antifungal performance and mite prevention performance, Sample 10 exhibits excellent antibacterial performance, antifungal performance and mite prevention performance, but has a large decrease in strength. Therefore, in practice, the amount of the mixture of the regenerated chitosan microparticles and the antibacterial and antifungal agent A is preferably 0.3 to 2.0% based on cellulose.

【0052】〔実施例3〕脱アセチル化度82%、平均
分子量45,000のキトサン500gを酢酸250g
を含む7,750gに加えて溶解しキトサン酢酸水溶液
を得た。この溶液の20℃における粘度は回転粘度計で
測定したところ3,400cps であった。このキトサン
酸性溶液を5%苛性ソーダ水溶液中に落下させて、粒状
に凝固再生させた。
Example 3 500 g of chitosan having a degree of deacetylation of 82% and an average molecular weight of 45,000 was added to 250 g of acetic acid.
Was added to and dissolved in 7,750 g to obtain an aqueous solution of chitosan acetic acid. The viscosity of this solution at 20 ° C. was 3,400 cps as measured by a rotational viscometer. This chitosan acidic solution was dropped into a 5% aqueous solution of caustic soda, and solidified and regenerated in granular form.

【0053】この凝固物を中性になるまで十分水で洗浄
した後、実施例1と同様に、15,000rpm の回転数
で3分間ずつ3回繰り返し粉砕分散させ乳状の懸濁液と
した。これを120メッシュの篩で粗大片を濾別し、攪
拌機で攪拌しながら、濾液を3.0kg/cm2 の加圧空気
と共に毎分16mlの流量で170〜180℃の高温雰
囲気中に吐出して乾燥し、乾燥物をサイクロンコレクタ
ーに捕集した。該乾燥物を風力分級機((株)セイシン
企業製、商品名スペディック250)を用いて、分級し
て粒子径5μm以下の再生キトサン微小粒状体300g
を得た。
After the coagulated product was sufficiently washed with water until it became neutral, it was repeatedly pulverized and dispersed three times at 15,000 rpm for 3 minutes to obtain a milky suspension as in Example 1. This was filtered through a 120-mesh sieve to remove coarse pieces, and the filtrate was discharged together with 3.0 kg / cm 2 of pressurized air at a flow rate of 16 ml / min into a high-temperature atmosphere of 170 to 180 ° C. while stirring with a stirrer. The dried product was collected by a cyclone collector. The dried product was classified using an air classifier (trade name: Spedick 250, manufactured by Seishin Enterprise Co., Ltd.) and 300 g of regenerated chitosan fine particles having a particle diameter of 5 μm or less were classified.
I got

【0054】この再生キトサン微小粒状体に対して、実
施例1で用いた市販の抗菌抗黴剤Aを添加し、再生キト
サン微小粒状体と抗菌抗黴剤Aとの混合比(重量比)
(再生キトサン微小粒状体/抗菌抗黴剤A)が0/10
0,10/90,20/80,50/50,80/2
0,90/10,100/0となるように調整した。
The commercially available antibacterial and antifungal agent A used in Example 1 was added to the regenerated chitosan microparticles, and the mixture ratio (weight ratio) of the regenerated chitosan microparticles and the antibacterial antifungal agent A was added.
(Regenerated chitosan microparticles / antibacterial antifungal agent A) 0/10
0, 10/90, 20/80, 50/50, 80/2
It was adjusted to be 0, 90/10, 100/0.

【0055】これらの再生キトサン微小粒状体と抗菌抗
黴剤Aの混合物を、従来法によって得られたレーヨンビ
スコース(セルロース9.0%、全アルカリ6.0%、
全硫黄2.5%)各15リットルに、セルロースに対
し、2.0重量%の添加量になるように予め水に分散さ
せておいたそれぞれの再生キトサン微小粒状体と抗菌抗
黴剤A混合物分散液を添加し、均一にレーヨンビスコー
スに混合し、脱泡後、実施例1と同様に紡糸し、通常の
二浴緊張紡糸法により延伸し38mmに切断後、通常の精
練乾燥処理をして、3デニールの抗菌性セルロース再生
繊維をそれぞれ試料11〜17として糸切れなく製造し
て得た。これらの試料11〜17の繊度,乾強度,湿強
度,結節強度,吸湿性を測定し、その結果を表6に、抗
菌性能,抗カビ性能,防ダニ性能の測定結果を表7に示
した。
A mixture of the regenerated chitosan microparticles and the antibacterial and antifungal agent A was mixed with rayon viscose (9.0% cellulose, 6.0% total alkali,
A mixture of each regenerated chitosan microparticles and antibacterial and antifungal agent A, which were dispersed in water in advance so that the amount of addition was 2.0% by weight with respect to cellulose in 15 liters of each of 15 liters. The dispersion was added, uniformly mixed with rayon viscose, defoamed, spun in the same manner as in Example 1, stretched by a usual two-bath tension spinning method, cut into 38 mm, and then subjected to a usual scouring and drying treatment. Then, 3 denier antibacterial regenerated cellulose fibers were produced as Samples 11 to 17 without breakage. The fineness, dry strength, wet strength, knot strength and hygroscopicity of these samples 11 to 17 were measured, and the results are shown in Table 6, and the measurement results of antibacterial performance, antifungal performance and mite prevention performance are shown in Table 7. .

【0056】[0056]

【表6】 [Table 6]

【0057】[0057]

【表7】 [Table 7]

【0058】表6,表7から明らかなように、再生キト
サン微小粒状体と抗菌抗黴剤Aを同時にレーヨンビスコ
ースに添加し紡糸して得た抗菌性セルロース再生繊維は
優れた吸湿性を有すると共に、抗菌性能,抗カビ性能,
防ダニ性能を併せ具備しているが、試料11は吸湿性が
小さく、試料17は抗カビ性が劣っている。従って、実
用上再生キトサン微小粒状体と抗菌抗黴剤Aの混合物中
の再生キトサン微小粒状体の割合は再生キトサン微小粒
状体と抗菌抗黴剤Aの混合物をセルロース重量に対し
2.0%添加したときは10〜90%が好ましい。
As is clear from Tables 6 and 7, the antibacterial cellulose regenerated fiber obtained by simultaneously adding the regenerated chitosan microparticles and the antibacterial and antifungal agent A to rayon viscose and spinning have excellent hygroscopicity. Along with antibacterial performance, antifungal performance,
Although it has both anti-mite properties, Sample 11 has low hygroscopicity and Sample 17 has inferior mold resistance. Therefore, in practice, the ratio of the regenerated chitosan microparticles in the mixture of the regenerated chitosan microparticles and the antibacterial antifungal agent A is 2.0% by weight of the mixture of the regenerated chitosan microparticles and the antibacterial antifungal agent A based on the weight of cellulose. In this case, 10% to 90% is preferable.

【0059】〔実施例4〕脱アセチル化度87%、平均
分子量45,000のキトサン500gを、酢酸250
gを含む水7,500gに溶解して、25℃における粘
度3,300cpsのキトサン酢酸水溶液を得た。これを
10%苛性ソーダ、20%水からなる塩基性水溶液中
に、孔径0.25mmの孔より圧力下で一定量ずつ落下さ
せ粒状に凝固再生させた。これを中性になるまで十分洗
浄し再生キトサン粒状物を得た。これをエタノールで4
回置換した後、等モルの無水酢酸を用いて、常温で24
時間反応させた後、エタノールで洗浄後水洗し、0.5
N苛性ソーダでエステル結合を切断のため、室温で1時
間反応させ水洗し、脱アセチル化度25%の再生アセチ
ル化キトサン5.0リットルを得た。
Example 4 500 g of chitosan having a degree of deacetylation of 87% and an average molecular weight of 45,000 was added to acetic acid 250
g of water containing 7,300 g of a chitosan acetic acid aqueous solution having a viscosity of 3,300 cps at 25 ° C. This was dropped into a basic aqueous solution composed of 10% caustic soda and 20% water under a pressure from a hole having a pore diameter of 0.25 mm by a predetermined amount to be solidified and regenerated in a granular form. This was sufficiently washed until it became neutral to obtain regenerated chitosan granules. This with ethanol 4
After substitution twice, use equimolar acetic anhydride at room temperature for 24 hours.
After reacting for an hour, wash with ethanol and water,
In order to cut the ester bond with N caustic soda, the mixture was reacted at room temperature for 1 hour and washed with water to obtain 5.0 l of regenerated acetylated chitosan having a degree of deacetylation of 25%.

【0060】該再生アセチル化キトサン5.0リットル
に水4.75リットルを加えてホモジナイザーで17,
000rpm で5分間2回繰り返し粉砕し、更に、水4.
75リットルを加えて濃度3.47%の分散液とした。
これを14ml/分の流速で3.6kg/cm2 の加圧空気と
共に18℃の高温雰囲気中に吐出乾燥させ、乾燥物をサ
イクロンコレクターに捕集し、該乾燥物を実施例1と同
様に分級機で分級して、粒子径5μm以下の再生アセチ
ル化キトサン微小粒状体200gを得た。
To 5.0 liters of the regenerated acetylated chitosan, 4.75 liters of water was added, and the mixture was mixed with a homogenizer to obtain 17.
Crushing twice for 5 minutes at 000 rpm, and
75 liters were added to obtain a dispersion having a concentration of 3.47%.
This was discharged and dried at a flow rate of 14 ml / min together with 3.6 kg / cm 2 of pressurized air into a high-temperature atmosphere of 18 ° C., and the dried product was collected in a cyclone collector. Classification was performed by a classifier to obtain 200 g of regenerated acetylated chitosan microparticles having a particle diameter of 5 μm or less.

【0061】この再生アセチル化キトサン微小粒状体に
対して、実施例1で用いた市販の抗菌抗黴剤Aを再生ア
セチル化キトサン微小粒状体と抗菌抗黴剤Aが80対2
0(重量比)となるように添加し、再生アセチル化キト
サン微小粒状体と抗菌抗黴剤Aの混合物250gを得
た。
To the regenerated acetylated chitosan microparticles, the commercially available antibacterial and antifungal agent A used in Example 1 was mixed with the regenerated acetylated chitosan microparticles and the antibacterial and antifungal agent A at a ratio of 80: 2.
0 (weight ratio) to obtain 250 g of a mixture of the regenerated acetylated chitosan microparticles and the antibacterial antifungal agent A.

【0062】これを実施例2と同様にしてポリノジック
ビスコースに添加混合して、紡糸し同様の処理をして、
1.25デニール×38mmの抗菌性セルロース再生繊維
を、糸切れなくそれぞれ試料18〜22として製造して
得た。試料18〜22の繊度,乾強度,湿強度,結節強
度,吸湿性を測定し、その結果を表8に、抗菌性能,抗
カビ性能,防ダニ性能の測定結果を表9に示した。
This was added to and mixed with polynosic viscose in the same manner as in Example 2, spun and subjected to the same treatment.
Antibacterial cellulose regenerated fibers of 1.25 denier x 38 mm were produced and produced as samples 18 to 22 without thread breakage, respectively. The fineness, dry strength, wet strength, knot strength and hygroscopicity of Samples 18 to 22 were measured, and the results are shown in Table 8, and the measurement results of antibacterial performance, antifungal performance, and anti-mite performance are shown in Table 9.

【0063】[0063]

【表8】 [Table 8]

【0064】[0064]

【表9】 [Table 9]

【0065】表8,表9から明らかなように、再生アセ
チル化キトサン微小粒状体と抗菌抗黴剤Aを混合し同時
にポリノジックビスコースに添加し紡糸して得た抗菌性
セルロース再生繊維は優れた吸湿性を有すると共に、抗
菌性能,抗カビ性能,防ダニ性能を併せ具備している
が、試料22は優れた抗菌性能,抗カビ性能,防ダニ性
能を発現するものの強力低下が大きい。従って、実用上
再生アセチル化キトサン微小粒状体と抗菌抗黴剤Aの混
合物の添加量は再生アセチル化キトサン微小粒状体と抗
菌抗黴剤Aの混合物の比率が80対20(重量比)のと
きにセルロースに対して0.3〜2.0%が好ましい。
As is clear from Tables 8 and 9, the antibacterial cellulose regenerated fiber obtained by mixing the regenerated acetylated chitosan microparticles and the antibacterial antifungal agent A, and simultaneously adding the mixture to polynosic viscose and spinning was excellent. While having hygroscopicity, it also has antibacterial performance, antifungal performance, and anti-mite performance. Sample 22 exhibits excellent antibacterial performance, anti-fungal performance, and anti-mite performance, but has a large decrease in strength. Therefore, in practice, the amount of the mixture of the regenerated acetylated chitosan microparticles and the antibacterial antifungal agent A is as follows when the ratio of the mixture of the regenerated acetylated chitosan microparticles and the antibacterial antifungal agent A is 80:20 (weight ratio). The content is preferably 0.3 to 2.0% based on cellulose.

【0066】[0066]

【発明の効果】上述の実施例から明らかなように、本発
明によれば、セルロース再生繊維中に粒子径10μm以
下の再生キトサン微小粒状体又は再生アセチル化キトサ
ン微小粒状体,ニトリル系抗菌剤,ピリジン系抗菌剤,
ハロアルキルチオ系抗菌剤,有機ヨード系抗菌剤,チア
ゾール系抗菌剤及びベンツイミダゾール系抗菌剤を同時
に、セルロースに対して0.3〜2.0%(重量)含有
せしめ、また、再生キトサン微小粒状体又は再生アセチ
ル化キトサン微小粒状体が混合させる抗菌剤の合計に対
し10〜90%含有させることによって、セルロース再
生繊維が本来有する物性、風合い等の性能を損うことな
く、優れた吸湿性を有し、抗菌性能,抗カビ性能,防ダ
ニ性能を併せ具備する抗菌性セルロース再生繊維を提供
することが出来る。
As is clear from the above examples, according to the present invention, regenerated chitosan microparticles or regenerated acetylated chitosan microparticles having a particle size of 10 μm or less in regenerated cellulose fibers, nitrile antibacterial agents, Pyridine antibacterial agent,
A haloalkylthio antibacterial agent, an organic iodine antibacterial agent, a thiazole antibacterial agent and a benzimidazole antibacterial agent are simultaneously contained in cellulose in an amount of 0.3 to 2.0% (by weight) with respect to cellulose. Alternatively, by adding 10 to 90% of the total amount of the antibacterial agent mixed with the regenerated acetylated chitosan microparticles, the cellulose regenerated fiber has excellent hygroscopicity without impairing the inherent properties and texture of the regenerated cellulose fiber. In addition, it is possible to provide an antibacterial cellulose regenerated fiber having both antibacterial performance, antifungal performance, and anti-mite performance.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 セルロース再生繊維中に粒子径10μm
以下の再生キトサン微小粒状体、ニトリル系抗菌剤、ピ
リジン系抗菌剤、ハロアルキルチオ系抗菌剤、有機ヨー
ド系抗菌剤、チアゾール系抗菌剤、及びベンツイミダゾ
ール系抗菌剤を含有していることを特徴とする抗菌性セ
ルロース再生繊維。
1. The cellulose regenerated fiber has a particle diameter of 10 μm.
It is characterized by containing the following regenerated chitosan microparticles, a nitrile antibacterial agent, a pyridine antibacterial agent, a haloalkylthio antibacterial agent, an organic iodine antibacterial agent, a thiazole antibacterial agent, and a benzimidazole antibacterial agent. Antibacterial cellulose regenerated fiber.
【請求項2】 再生キトサン微小粒状体が再生アセチル
化キトサン微小粒状体である請求項1記載の抗菌性セル
ロース再生繊維。
2. The regenerated antibacterial cellulose fiber according to claim 1, wherein the regenerated chitosan microparticles are regenerated acetylated chitosan microparticles.
JP20521296A 1996-07-16 1996-07-16 Antibacterial cellulose regenerated fiber Expired - Fee Related JP3413631B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20521296A JP3413631B2 (en) 1996-07-16 1996-07-16 Antibacterial cellulose regenerated fiber

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20521296A JP3413631B2 (en) 1996-07-16 1996-07-16 Antibacterial cellulose regenerated fiber

Publications (2)

Publication Number Publication Date
JPH1037018A true JPH1037018A (en) 1998-02-10
JP3413631B2 JP3413631B2 (en) 2003-06-03

Family

ID=16503267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20521296A Expired - Fee Related JP3413631B2 (en) 1996-07-16 1996-07-16 Antibacterial cellulose regenerated fiber

Country Status (1)

Country Link
JP (1) JP3413631B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001123367A (en) * 1999-10-22 2001-05-08 Toray Ind Inc Fiber structure
EP1243688A1 (en) * 2001-03-22 2002-09-25 Cognis Iberia, S.L. Use of chitosan nanoparticles
CN1099477C (en) * 2000-01-14 2003-01-22 东华大学 Antibacterial fibres containing chitin and its derivatives, and preparing process thereof
AT410806B (en) * 1999-08-26 2003-08-25 Chemiefaser Lenzing Ag Viscose or lyocell cellulose fibers useful for making textiles comprise a deodorizing ceramic material and a bacteriostatic organic material
CN101935893A (en) * 2010-08-27 2011-01-05 山东海龙股份有限公司 Multifunctional aromatic antibiosis viscose fiber and preparation method thereof
US8524326B2 (en) 2008-01-22 2013-09-03 Lenzing Aktiengesellschaft Process for the treatment of cellulosic molded bodies
CN107012525A (en) * 2017-06-01 2017-08-04 合肥创沃科技有限公司 A kind of preparation method of the composite regenerated cellulose tissue repair materials of chitosan

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410806B (en) * 1999-08-26 2003-08-25 Chemiefaser Lenzing Ag Viscose or lyocell cellulose fibers useful for making textiles comprise a deodorizing ceramic material and a bacteriostatic organic material
JP2001123367A (en) * 1999-10-22 2001-05-08 Toray Ind Inc Fiber structure
CN1099477C (en) * 2000-01-14 2003-01-22 东华大学 Antibacterial fibres containing chitin and its derivatives, and preparing process thereof
EP1243688A1 (en) * 2001-03-22 2002-09-25 Cognis Iberia, S.L. Use of chitosan nanoparticles
WO2002077358A1 (en) * 2001-03-22 2002-10-03 Cognis Iberia S.L. Use of nanochitosanes
US8524326B2 (en) 2008-01-22 2013-09-03 Lenzing Aktiengesellschaft Process for the treatment of cellulosic molded bodies
CN101935893A (en) * 2010-08-27 2011-01-05 山东海龙股份有限公司 Multifunctional aromatic antibiosis viscose fiber and preparation method thereof
CN107012525A (en) * 2017-06-01 2017-08-04 合肥创沃科技有限公司 A kind of preparation method of the composite regenerated cellulose tissue repair materials of chitosan

Also Published As

Publication number Publication date
JP3413631B2 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
DE69916070T2 (en) PROCESS FOR THE PREPARATION OF ANTIMICROBIAL OBJECTS
JP4658813B2 (en) Antibacterial fibers, woven or knitted fabrics, non-woven fabrics, wallpaper, and insulation
TWI482891B (en) Lyocell fibre, and process for the manufacture and use thereof
JP6539734B2 (en) Liquid-impregnated nonwoven comprising zinc oxide-containing cellulose fibers, method of producing the nonwoven, and use of the nonwoven for producing the wet wipe
JP5496195B2 (en) Fiber containing iodine and amylose, process for producing the same and use thereof
CA2402181A1 (en) Stabilized microfibrillar cellulose
CN107326470A (en) A kind of processing method of the lasting modified polyester fiber of antibacterial
CH680255A5 (en)
BRPI0707471A2 (en) resin composition containing controlled release agricultural chemical, production method thereof and agricultural chemical formulation
JP3413631B2 (en) Antibacterial cellulose regenerated fiber
BR112014014586B1 (en) biocidal composition of active powders, manufacturing procedure for the biocidal composition and its use
CN109958001A (en) Bactericidal properties high polymer nanometer fiber aggregation and dry sanitation paper using it
US4480089A (en) Modified cellulose products by bleaching
JP2571738B2 (en) Non-woven
CN101554161A (en) Dimethomorph-mancozeb water dispersible granule and preparation method thereof
EP2819711B1 (en) Antiseptic wound dressing
CN111364139A (en) Antibacterial polyester fiber blended yarn and preparation method thereof
DE602004004090T2 (en) FOR UNIQUE USE IN HOSPITAL AND OPERATIONAL ROOM, SPECIFIC PRODUCTS BASED ON PAPER
JP3637892B2 (en) Antibacterial packaging material
DE10037983B4 (en) Polymer composition and molded articles containing it containing alkaloid
JP2802988B2 (en) Modified cellulose regenerated fiber
RU2324776C2 (en) Cellulose fibre
JP3893116B2 (en) Allergen reducing agent
CN107447279A (en) A kind of long-acting biological antibacterial nonwoven cloth and preparation method thereof
JP3887053B2 (en) Antibacterial fiber product and its manufacturing method

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090404

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090404

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100404

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 8

Free format text: PAYMENT UNTIL: 20110404

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130404

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees